AGC Biologics A/S: Financial statements 2014
CVR: 25950941
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
AGC Biologics A/S (CVR 25950941) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 311,091,000 and a net result of DKK 3,181,000 compared with DKK -128,000 the year before. The profit margin was 1%. Equity in the 2014 report amounted to DKK 139,522,000. The solvency ratio was 40.3%. The company had 199 employees in the financial year.
- Revenue
- DKK 311,091,000
- Gross Profit
- DKK 45,843,000
- Profit/Loss
- DKK 3,181,000
- Equity
- DKK 139,522,000
- Total Assets
- DKK 346,594,000
- Employees
- 199
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 311.1M | 45.8M | 3.2M | 139.5M | 199 |
| 2013 | - | 37.2M | -128K | 136.3M | 185 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of June 27, 2014, Jesper Bramming has joined the board of directors of AGC Biologics A/S.
As of June 27, 2014, Mads Aage Laustsen has left the board of directors of AGC Biologics A/S.
AGC Biologics A/S has published its annual report for 2013. Gross profit came to DKK 37,248,000, and the net result was DKK -128,000.
As of January 14, 2014, Mads Aage Laustsen has joined the board of directors of AGC Biologics A/S.
As of January 14, 2014, Patricio Ezequiel Massera has joined the board of directors of AGC Biologics A/S.
As of January 14, 2014, David Kauffmann has left the board of directors of AGC Biologics A/S.
As of January 14, 2014, Claès Johan Robert Glassell has left the board of directors of AGC Biologics A/S.
As of January 14, 2014, Mads Aage Laustsen has stepped down as director of AGC Biologics A/S.
As of January 14, 2014, Claès Johan Robert Glassell has stepped down as director of AGC Biologics A/S.
As of January 14, 2014, Gustavo Fabio Mahler has stepped down as director of AGC Biologics A/S.
About AGC Biologics A/S
AGC Biologics A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2001. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named CMC BIOLOGICS A/S and CMC BIOPHARMACEUTICALS A/S. The management consists of Kasper Møller. The board consists of Tadashi Murano (chair), Alberto Santagostino, Kasper Møller and Mai Iwaya. The company is owned by Asahi Glass Co., Ltd.. The company has 1,503 employees (2026). In 2025, the company reported revenue of DKK 1,959,639,000 and a net result of DKK -328,010,000 compared with DKK -115,005,000 the year before. Equity in the 2025 report amounted to DKK 312,021,000.
